Study Stopped
Recruitment was unsuccessful
Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction
Delfi
1 other identifier
interventional
7
1 country
1
Brief Summary
The aim of this study is to determine if there is a difference in post operative rehabilitation after anterior cruciate ligament (ACL) reconstruction surgery while using moderated blood flow therapy vs. standard physical therapy. All patients undergoing ACL reconstruction, between the ages of 18-30, that consent to taking part in the study, and meet eligibility criteria, will be included in the study. Patients will be followed for two years to determine any differences in muscle strength, thigh circumference, knee range of motion, pain, functional and activity levels, patient satisfaction, levels of Human growth hormone HGH), Insulin-like Growth Factor (IGF), and Creatine Kinase (CK), KT2000, and Lachman physical examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 22, 2016
CompletedStudy Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2019
CompletedResults Posted
Study results publicly available
March 11, 2020
CompletedMarch 11, 2020
March 1, 2020
2.1 years
August 5, 2016
November 4, 2019
March 5, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Muscle Strength
Compare mean peak muscle strength at 60 degrees of knee flexion (during extension) of the involved leg between the blood restriction and the control groups
12 months
Secondary Outcomes (10)
Range of Motion
12 months
Tegner Activity Survey Score
12 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Survey Score.
12 months
International Knee Documentation Committee (IKDC) Survey Score
12 months
Visual Analog Scale (VAS)
12 months
- +5 more secondary outcomes
Study Arms (2)
Standard rehabilitation
ACTIVE COMPARATORPatients will receive standard post-operative ACL rehabilitation
Delfi moderated blood flow restriction
EXPERIMENTALPatients will receive Delfi moderated blood flow post-operative ACL rehabilitation
Interventions
Patients will receive standard of care post-operative ACL reconstruction rehabilitation plus the Delfi moderated blood flow restriction therapy.
Patients will receive standard of care post-operative ACL reconstruction rehabilitation
Eligibility Criteria
You may qualify if:
- Patients between 18-30 years of age.
- Diagnosis of isolated anterior cruciate ligament (ACL) tear and pending ACL reconstruction.
You may not qualify if:
- age \<18 years old or \>30 years old
- Multi-ligament knee injury
- Revision ACL reconstruction
- History or peripheral vascular disease
- History of deep vein thrombosis or pulmonary embolism
- Any contraindication to moderated blood flow restriction therapy
- Inability to comply with post-operative ACL reconstruction rehabilitation
- If meniscal repair or a cartilage procedure is performed at the time of surgery that would preclude the patient from being able to follow the standard post-operative ACL rehabilitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Missouri Orthopaedic Institute
Columbia, Missouri, 65212, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Finding patients that meet all the inclusion criteria was cumbersome. Some patients after enrollment had intra-operative findings that would later make them not eligible to keep participating in the study (required procedures beyond ACL recon)
Results Point of Contact
- Title
- Ennio Rizzo
- Organization
- University of Missouri
Study Officials
- PRINCIPAL INVESTIGATOR
James Cook
University of MO-Columbia
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- William & Kathryn Allen Distinguished Professor in Orthopaedic Surgery
Study Record Dates
First Submitted
August 5, 2016
First Posted
September 22, 2016
Study Start
October 1, 2017
Primary Completion
October 21, 2019
Study Completion
October 21, 2019
Last Updated
March 11, 2020
Results First Posted
March 11, 2020
Record last verified: 2020-03